{
  "ticker": "NMR",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02962058",
  "id": "02962058",
  "pages": 4,
  "price_sensitive": false,
  "date": "20250625",
  "time": "1727",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250625/pdf/06l3c06kgxg7ll.pdf",
  "summary": "- **Change of Director\u2019s Interest (Amendment)**:  \n  - **Director**: Blake Cannavo (MD & CEO) indirectly sold **20,000,000 shares** via BOC Holdings Pty Ltd entities.  \n  - **Value**: **$3.2 million** (off-market sale).  \n  - **Purpose**: Repayment of company debt secured by personal guarantee to Collins St Convertible Notes Pty Limited.  \n  - **Post-transaction holdings**:  \n    - **Shares**: 142,263,384 (indirect) + 10,355,408 (direct).  \n    - **Options**: Unchanged (see prior filing).  \n\n*No material trading or capital markets impact identified beyond the disclosure.*",
  "usage": {
    "prompt_tokens": 1742,
    "completion_tokens": 149,
    "total_tokens": 1891,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-25T07:56:56.172935"
}